TRI 0.00% 2.9¢ trivarx ltd

Future of MediBio, page-53

  1. 507 Posts.
    lightbulb Created with Sketch. 333
    Absolutely! It’s a much neededtechnology with a massive potential.


    IMO problem is the Board’s baddecisions and Management's poor performance.

    • Company has failed to sign up even 1 Commercial ‘Ilumen’ Corporate Health contract since we have launched the product. Wonder what these people with fancy titles do? Who is incharge of Business Development and Marketing ??? Do we have any KPI's ???
    • Instead of spending $1 million on the legal cost in first half, Company should have engaged one of the best in town regulatory consultant to get a better guidance in regards to FDA Reg. clearance strategy.
    • Company was suppose to straight start working on revised CE Mark submission at least 6 months ago.
    • Would have timely strategies to commercialize products into EU region and should have alliance into potential distributors and channel partners.
    • Company should have timely assessed that FDA 510 wasn’t a best route. Who is responsible for wasting 6 months of time, resources and money ?
    • Failed capital raising. What is the plan in regards to raising capital... at what price we will be raising $3 million.

    We all had enough blaming to previous Management. That chapter is closed now!

    New Management is in full control for over 7 months now. Instead of blaming previous management decisions, Its time for the new Management to start delivering performance.

    All above comments are my own opinions - DYOR!
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
(20min delay)
Last
2.9¢
Change
0.000(0.00%)
Mkt cap ! $9.816M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 174756 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 74032 1
View Market Depth
Last trade - 19.00pm 29/03/2024 (20 minute delay) ?
TRI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.